Unique pharmacology of KAR-2, a potential anti-cancer agent: Absorption modelling and selective mitotic spindle targeting

Isabel Gonzalez-Alvarez, Marta Gonzalez-Alvarez, Davinia Oltra-Noguera, Virginia Merino, Natália Tõkési, J. Ovádi, Marival Bermejo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Bis-indols are a large group of the anti-cancer agents, which effectively arrest the uncontrolled division of the cancerous cells. Their use in clinical chemotherapy is still limited because of: (i) the non-specific targeting of the mitotic cells; (ii) low bioavailability of the drugs. KAR-2 has been identified as a tubulin binding agent which displays significantly lower cytotoxicity but favourable anti-cancer potency than its mother molecule, vinblastine. The objective of this paper, on one hand, was to show that the human intestinal epithelial Caco-2 cells, used for pharmacokinetic studies display distinct sensitivity against KAR-2 and vinblastine due to their distinct targeting of mitotic and interphase microtubular systems. We showed that KAR-2 impeded specifically the cell division. On the other hand, we elucidated the transport mechanisms of KAR-2 as compared to vinblastine, applying pharmacokinetic modelling based upon the combination of the data obtained from in situ animal and in vitro cell level experiments. The Caco-2 cell line and in in situ intestinal perfusion experiments in rat small intestine showed that vinblastine and KAR-2 are substrates of secretion transporters but with different affinity and KAR-2 presents a higher passive diffusion permeability. The information obtained from the kinetic modelling of each type of experiments rendered it possible to apply a single mathematical model to the whole (in vitro and in situ) data set including the adequate scale-up parameters. The model was validated by means of a model selection procedure based on the goodness of fit indexes to the experimental data. This unified quantitative model which characterizes the absorption/efflux features of KAR-2 as compared to vinblastine revealed its more favourable intestinal permeability. In addition, our pharmacokinetic analyses evaluated in this study showed the advantages of the modelling approach in maximizing of the information obtained from experimental data.

Original languageEnglish
Pages (from-to)11-19
Number of pages9
JournalEuropean Journal of Pharmaceutical Sciences
Volume36
Issue number1
DOIs
Publication statusPublished - Jan 31 2009

Fingerprint

Spindle Apparatus
Vinblastine
Pharmacology
Neoplasms
Caco-2 Cells
Pharmacokinetics
Cell Division
Permeability
Interphase
Tubulin
deacetoxyvinzolidine
Biological Availability
Small Intestine
Theoretical Models
Perfusion
Epithelial Cells
Drug Therapy
Cell Line
Pharmaceutical Preparations

Keywords

  • In situ-in vitro correlation
  • KAR-2
  • Permeability
  • Vinblastine

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Unique pharmacology of KAR-2, a potential anti-cancer agent : Absorption modelling and selective mitotic spindle targeting. / Gonzalez-Alvarez, Isabel; Gonzalez-Alvarez, Marta; Oltra-Noguera, Davinia; Merino, Virginia; Tõkési, Natália; Ovádi, J.; Bermejo, Marival.

In: European Journal of Pharmaceutical Sciences, Vol. 36, No. 1, 31.01.2009, p. 11-19.

Research output: Contribution to journalArticle

Gonzalez-Alvarez, Isabel ; Gonzalez-Alvarez, Marta ; Oltra-Noguera, Davinia ; Merino, Virginia ; Tõkési, Natália ; Ovádi, J. ; Bermejo, Marival. / Unique pharmacology of KAR-2, a potential anti-cancer agent : Absorption modelling and selective mitotic spindle targeting. In: European Journal of Pharmaceutical Sciences. 2009 ; Vol. 36, No. 1. pp. 11-19.
@article{c6d09cd3c98f4c0fbaa09ea78ff22e07,
title = "Unique pharmacology of KAR-2, a potential anti-cancer agent: Absorption modelling and selective mitotic spindle targeting",
abstract = "Bis-indols are a large group of the anti-cancer agents, which effectively arrest the uncontrolled division of the cancerous cells. Their use in clinical chemotherapy is still limited because of: (i) the non-specific targeting of the mitotic cells; (ii) low bioavailability of the drugs. KAR-2 has been identified as a tubulin binding agent which displays significantly lower cytotoxicity but favourable anti-cancer potency than its mother molecule, vinblastine. The objective of this paper, on one hand, was to show that the human intestinal epithelial Caco-2 cells, used for pharmacokinetic studies display distinct sensitivity against KAR-2 and vinblastine due to their distinct targeting of mitotic and interphase microtubular systems. We showed that KAR-2 impeded specifically the cell division. On the other hand, we elucidated the transport mechanisms of KAR-2 as compared to vinblastine, applying pharmacokinetic modelling based upon the combination of the data obtained from in situ animal and in vitro cell level experiments. The Caco-2 cell line and in in situ intestinal perfusion experiments in rat small intestine showed that vinblastine and KAR-2 are substrates of secretion transporters but with different affinity and KAR-2 presents a higher passive diffusion permeability. The information obtained from the kinetic modelling of each type of experiments rendered it possible to apply a single mathematical model to the whole (in vitro and in situ) data set including the adequate scale-up parameters. The model was validated by means of a model selection procedure based on the goodness of fit indexes to the experimental data. This unified quantitative model which characterizes the absorption/efflux features of KAR-2 as compared to vinblastine revealed its more favourable intestinal permeability. In addition, our pharmacokinetic analyses evaluated in this study showed the advantages of the modelling approach in maximizing of the information obtained from experimental data.",
keywords = "In situ-in vitro correlation, KAR-2, Permeability, Vinblastine",
author = "Isabel Gonzalez-Alvarez and Marta Gonzalez-Alvarez and Davinia Oltra-Noguera and Virginia Merino and Nat{\'a}lia T{\~o}k{\'e}si and J. Ov{\'a}di and Marival Bermejo",
year = "2009",
month = "1",
day = "31",
doi = "10.1016/j.ejps.2008.10.020",
language = "English",
volume = "36",
pages = "11--19",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Unique pharmacology of KAR-2, a potential anti-cancer agent

T2 - Absorption modelling and selective mitotic spindle targeting

AU - Gonzalez-Alvarez, Isabel

AU - Gonzalez-Alvarez, Marta

AU - Oltra-Noguera, Davinia

AU - Merino, Virginia

AU - Tõkési, Natália

AU - Ovádi, J.

AU - Bermejo, Marival

PY - 2009/1/31

Y1 - 2009/1/31

N2 - Bis-indols are a large group of the anti-cancer agents, which effectively arrest the uncontrolled division of the cancerous cells. Their use in clinical chemotherapy is still limited because of: (i) the non-specific targeting of the mitotic cells; (ii) low bioavailability of the drugs. KAR-2 has been identified as a tubulin binding agent which displays significantly lower cytotoxicity but favourable anti-cancer potency than its mother molecule, vinblastine. The objective of this paper, on one hand, was to show that the human intestinal epithelial Caco-2 cells, used for pharmacokinetic studies display distinct sensitivity against KAR-2 and vinblastine due to their distinct targeting of mitotic and interphase microtubular systems. We showed that KAR-2 impeded specifically the cell division. On the other hand, we elucidated the transport mechanisms of KAR-2 as compared to vinblastine, applying pharmacokinetic modelling based upon the combination of the data obtained from in situ animal and in vitro cell level experiments. The Caco-2 cell line and in in situ intestinal perfusion experiments in rat small intestine showed that vinblastine and KAR-2 are substrates of secretion transporters but with different affinity and KAR-2 presents a higher passive diffusion permeability. The information obtained from the kinetic modelling of each type of experiments rendered it possible to apply a single mathematical model to the whole (in vitro and in situ) data set including the adequate scale-up parameters. The model was validated by means of a model selection procedure based on the goodness of fit indexes to the experimental data. This unified quantitative model which characterizes the absorption/efflux features of KAR-2 as compared to vinblastine revealed its more favourable intestinal permeability. In addition, our pharmacokinetic analyses evaluated in this study showed the advantages of the modelling approach in maximizing of the information obtained from experimental data.

AB - Bis-indols are a large group of the anti-cancer agents, which effectively arrest the uncontrolled division of the cancerous cells. Their use in clinical chemotherapy is still limited because of: (i) the non-specific targeting of the mitotic cells; (ii) low bioavailability of the drugs. KAR-2 has been identified as a tubulin binding agent which displays significantly lower cytotoxicity but favourable anti-cancer potency than its mother molecule, vinblastine. The objective of this paper, on one hand, was to show that the human intestinal epithelial Caco-2 cells, used for pharmacokinetic studies display distinct sensitivity against KAR-2 and vinblastine due to their distinct targeting of mitotic and interphase microtubular systems. We showed that KAR-2 impeded specifically the cell division. On the other hand, we elucidated the transport mechanisms of KAR-2 as compared to vinblastine, applying pharmacokinetic modelling based upon the combination of the data obtained from in situ animal and in vitro cell level experiments. The Caco-2 cell line and in in situ intestinal perfusion experiments in rat small intestine showed that vinblastine and KAR-2 are substrates of secretion transporters but with different affinity and KAR-2 presents a higher passive diffusion permeability. The information obtained from the kinetic modelling of each type of experiments rendered it possible to apply a single mathematical model to the whole (in vitro and in situ) data set including the adequate scale-up parameters. The model was validated by means of a model selection procedure based on the goodness of fit indexes to the experimental data. This unified quantitative model which characterizes the absorption/efflux features of KAR-2 as compared to vinblastine revealed its more favourable intestinal permeability. In addition, our pharmacokinetic analyses evaluated in this study showed the advantages of the modelling approach in maximizing of the information obtained from experimental data.

KW - In situ-in vitro correlation

KW - KAR-2

KW - Permeability

KW - Vinblastine

UR - http://www.scopus.com/inward/record.url?scp=58149129028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149129028&partnerID=8YFLogxK

U2 - 10.1016/j.ejps.2008.10.020

DO - 10.1016/j.ejps.2008.10.020

M3 - Article

C2 - 19028571

AN - SCOPUS:58149129028

VL - 36

SP - 11

EP - 19

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

IS - 1

ER -